3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
13
Breast Neoplasms
13
Pancreatic Neoplasms
10
Ovarian Neoplasms
10
Fallopian Tube Neoplasms
10
Lung Neoplasms
8
Triple Negative Breast Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
7
Neoplasm Metastasis
4
Esophageal Neoplasms
4
Endometrial Neoplasms
4
Oropharyngeal Neoplasms
3
Mouth Neoplasms
3
Melanoma
3
Inflammatory Breast Neoplasms
3
Hypopharyngeal Neoplasms
3
Head and Neck Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Transitional Cell
3
Carcinoma
3
Stomach Neoplasms
2
Pancreatic Adenocarcinoma
2
Neoplasms, Squamous Cell
2
Neoplasms
2
Laryngeal Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Cholangiocarcinoma
2
Carcinoma, Squamous Cell
2
Brenner Tumor
2
Adenocarcinoma of Lung
2
Interventions
paricalcitol
1
ivosidenib
1
Taxes
1
Neoadjuvant Therapy
1
Losartan
1
Hydroxychloroquine
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Pancreatic Ductal Adenocarcinoma
×
Taxes
×
Clear all
NCT04827953
2024-12-30
NUMANTIA
Nelum Corp
Phase 1/2
Active not recruiting
28 enrolled